Sage Journals: Discover world-class research

Retricted access

Research article

First published 2022-1

Antibody Response to BNT162b2 Vaccine in Immune Modifiers–Treated Psoriatic Patients

Felix Pavlotsky, Zvi Segal, Aviv Barzilai

Journal of Psoriasis and Psoriatic Arthritis®

Open access

Research article

First published 2025-7

Which type of vaccine is more beneficial for reducing the risk of deep vein thrombosis,CoronaVac,BNT162b2,or TURKOVAC?

Süleyman Yazıcı, Osman Fehmi Beyazal, Hasan Tezcan

Science Progress

Open access

Case report

First published 2024

Case report of transient polymyalgia rheumatica after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine

Kosuke Matsuzono, Shigeru Fujimoto

Sage Open Medical Case Reports

Retricted access

Research article

First published 2023-3

Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab

Ilaria Schiavoni, Eleonora Olivetta, Francesco Natalucci [...]

Lupus

Free access

Letter

First published 2022-10

Time of Day of BNT162b2 COVID-19 Immunization Affects Total SARS-CoV-2 Antibody Levels but Not Neutralizing Activity

Filippos Filippatos, Elizabeth-Barbara Tatsi, Vasiliki Efthymiou [...]

Journal of Biological Rhythms

Open access

Research article

First published 2022

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study

Panagiotis T. Diamantopoulos, Christos Stafylidis, Dimitra Vlachopoulou [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2024-4

Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus

Nuntawan Piyaphanee, Sirirat Charuvanij, Sutheera Thepveera [...]

Lupus

Retricted access

Review article

First published 2022-12

Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273

Shyh Poh Teo

Journal of Pharmacy Practice

Free access

Research article

First published 2024-1

Effectiveness of Pfizer-BioNTech (BNT162b2) Vaccine Among Adolescents (Aged 12-15 Years): An Observational Study in Qatar

Maktoum Abdul Azeez, Mir Saad Hussain, Shajitha Thekke Veettil [...]

Clinical Pediatrics

Open access

Case report

First published 2024

Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report

Jai Kumar Khatri, Ihab Tahboub, Khurram Anwar [...]

Journal of Investigative Medicine High Impact Case Reports

Search results